Literature DB >> 28289901

Overexpression of Rsf-1 correlates with poor survival and promotes invasion in non-small cell lung cancer.

Xiuwei Zhang1,2, Lin Fu1, Dongwei Xue3, Xiupeng Zhang1, Fengxia Hao1, Lingling Xie1, Jiani He1, Junda Gai1, Yuhui Liu1, Hongtao Xu1, Qingchang Li4, Enhua Wang1.   

Abstract

Rsf-1 (HBXAP) was recently reported to play roles in tumorigenesis and tumor progression. There have been many reports referred to Rsf-1 overexpression in various cancers and associated with the malignant behavior of cancer cells. However, the molecular mechanism of Rsf-1 in non-small cell lung cancer aggressiveness remains ambiguous. In the present study, we found that there was a significant association between Rsf-1 overexpression and poor overall survival (p = 0.028) in lung cancer. Furthermore, knockdown of Rsf-1 expression in H1299 and H460 cells with high endogenous Rsf-1 expression inhibited cell migration and invasion and downregulated MMP2 expression and nuclear levels of NF-κB. NF-κB inhibitor could also block the effect of Rsf-1 in regulation of MMP2 expression. Further experiments demonstrated that Rsf-1 depletion restrained NF-κB reporter luciferase activity and downregulated bcl-2 and p-IκB protein level. In conclusion, we demonstrated that Rsf-1 was overexpressed in lung cancer and associated with poor survival. Rsf-1 regulated cell invasion through MMP2 and NF-κB pathway.

Entities:  

Keywords:  MMP2; NF-κB; Non-small cell lung cancer; Rsf-1

Mesh:

Substances:

Year:  2017        PMID: 28289901     DOI: 10.1007/s00428-017-2102-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer.

Authors:  Chi Keung Cheng; Louis W C Chow; Wings T Y Loo; Tai Kwong Chan; Vivian Chan
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

2.  Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection.

Authors:  J Xu; T Tyan; E Cedrone; N Savaraj; N Wang
Journal:  Genes Chromosomes Cancer       Date:  1996-11       Impact factor: 5.006

3.  The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

Authors:  C Chen; L C Edelstein; C Gélinas
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.

Authors:  Ben Davidson; Claes G Trope'; Tian-Li Wang; Ie-Ming Shih
Journal:  Gynecol Oncol       Date:  2006-07-17       Impact factor: 5.482

5.  Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.

Authors:  Lindsay A Brown; Julie Irving; Robin Parker; Hanna Kim; Joshua Z Press; Teri A Longacre; Stephen Chia; Anthony Magliocco; Nikita Makretsov; Blake Gilks; Jonathan Pollack; David Huntsman
Journal:  Gynecol Oncol       Date:  2005-10-19       Impact factor: 5.482

Review 6.  Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review.

Authors:  Agnieszka Jezierska; Tomasz Motyl
Journal:  Med Sci Monit       Date:  2009-02

7.  The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Authors:  Hilary A Kenny; Swayamjot Kaur; Lisa M Coussens; Ernst Lengyel
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

8.  Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer.

Authors:  J Bostner; M Ahnström Waltersson; T Fornander; L Skoog; B Nordenskjöld; O Stål
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

Review 9.  Amplification of oncogenes in human cancer cells.

Authors:  M Schwab
Journal:  Bioessays       Date:  1998-06       Impact factor: 4.345

10.  First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer.

Authors:  A Rosen; P Sevelda; M Klein; K Dobianer; C Hruza; K Czerwenka; H Hanak; N Vavra; H Salzer; S Leodolter
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

View more
  8 in total

1.  Remodeling and spacing factor 1 overexpression is associated with poor prognosis in renal cell carcinoma.

Authors:  Xiuwei Zhang; Dongwei Xue; Fengxia Hao; Lingling Xie; Jiani He; Junda Gai; Yuhui Liu; Hongtao Xu; Qingchang Li; Enhua Wang
Journal:  Oncol Lett       Date:  2018-01-15       Impact factor: 2.967

2.  RSF1 requires CEBP/β and hSNF2H to promote IL-1β-mediated angiogenesis: the clinical and therapeutic relevance of RSF1 overexpression and amplification in myxofibrosarcomas.

Authors:  Chien-Feng Li; Ti-Chen Chan; Cheng-I Wang; Fu-Min Fang; Po-Chun Lin; Shih-Chen Yu; Hsuan-Ying Huang
Journal:  Angiogenesis       Date:  2021-01-26       Impact factor: 10.658

3.  Rsf‑1 regulates malignant melanoma cell viability and chemoresistance via NF‑κB/Bcl‑2 signaling.

Authors:  Jiani He; Lin Fu; Qingchang Li
Journal:  Mol Med Rep       Date:  2019-08-23       Impact factor: 2.952

4.  RSF-1 siRNA Enhances Tumor Radiosensitivity in Cervical Cancer via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis.

Authors:  Jing Tian; Enqi Kong; Xiangyu Wang; Zhaoguang Xie; Cherry Yin-Yi Chang; Jim Jinn-Chyuan Sheu; Quan Hao; Li Sun
Journal:  Onco Targets Ther       Date:  2020-04-09       Impact factor: 4.147

5.  HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3.

Authors:  Xuyang Hou; Leping Yang; Kunpeng Wang; Yan Zhou; Qinglong Li; Fanhua Kong; Xi Liu; Jun He
Journal:  Cancer Med       Date:  2020-12-06       Impact factor: 4.452

Review 6.  The emerging role of ISWI chromatin remodeling complexes in cancer.

Authors:  Yanan Li; Han Gong; Pan Wang; Yu Zhu; Hongling Peng; Yajuan Cui; Heng Li; Jing Liu; Zi Wang
Journal:  J Exp Clin Cancer Res       Date:  2021-11-04

7.  Post-Translational Regulation of the RSF1 Chromatin Remodeler under DNA Damage.

Authors:  Sunwoo Min; Yong Won Choi; Hansol Yun; Sujin Jo; Jae-Hoon Ji; Hyeseong Cho
Journal:  Mol Cells       Date:  2018-01-31       Impact factor: 5.034

8.  HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1-IT2-dependent manner.

Authors:  Xiao-Jin Wu; Yuan-Yuan Chen; Wen-Wen Guo; Tao Li; Hai-Bei Dong; Wei Wang; Min Xie; Gao-Lei Ma; Dong-Sheng Pei
Journal:  Mol Oncol       Date:  2020-05-06       Impact factor: 6.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.